Potential Roadblock For ImClone Systems Incorporated (JOBS) Deal

Although it spent weeks teasing investors about the identity of its suitor, ImClone failed to satisfy all of its shareholders that a $6.5 billion bid from Eli Lilly fairly values the biotech business.